BEIJING, Oct. 1, 2026 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, announced that the cumulative revenue-sharing, a model where production partners share earnings with iQIYI based on viewership, box office for its AIGC film series "The Ferry Man" has surpassed RMB 8 million (US$1.2 million) as of September 23, marking a new milestone for the series. This comes as the third instalment, "The Ferry Man: The Dream of the Princess", debuts on October 1 on iQIYI and iQIYI International.

Produced by iQIYI and GHY Culture & Media, the series' first two titles, "The Ferry Man: Butterfly Dream" and "The Ferry Man: The Dream of the Celestial Maiden", were released simultaneously on August 22 on iQIYI and iQIYI International, and quickly gained commercial traction, reflecting growing market confidence in iQIYI's AI-driven premium content.

Rooted in traditional Chinese culture, "The Ferry Man" is an established IP spanning long-form drama, online films, musicals, and short-form series, blending mythology, folklore, and contemporary themes. The new films use AI production to render classical Chinese philosophical imagery as cinematic worlds.

Redefining Production Efficiency

The success of "The Ferry Man" series demonstrates a robust end-to-end AIGC value chain, one that successfully integrates production efficiency, market validation, and strong financial returns. By incorporating AI into its core workflow, iQIYI has fundamentally optimized the filmmaking process.

According to Zhichao LI, producer of the series, the first two films moved from project initiation to launch in less than four months. "AI significantly improved efficiency during the preparation and production stages," Li said, noting that the script development and post-production processes remained largely consistent with traditional film and television workflows.

During production, AIGC was used to generate visual assets for concept design, sets, props, and other art elements, which could then be directly turned into video based on the director's creative requirements. This simplified parts of the traditional production process, including physical shoots and scene transitions, while giving creators greater flexibility. For a key scene in "The Ferry Man: The Dream of the Celestial Maiden", AI generation also streamlined a process that would traditionally involve months of visual effects and green-screen production, significantly improving production efficiency and making complex scenes more feasible to produce.

Leveraging Digital Assets for Long-Term Value

Unlike traditional productions, "The Ferry Man" series builds lasting digital asset value through AIGC. The three lead actors licensed their likenesses and provided their own voiceovers, with digital character assets, scenes, and props developed as standardized, reusable assets. These assets enable the upcoming third film to maintain visual consistency while significantly reducing production costs, establishing a scalable model for serialized content development.

Market Validation through Data-Driven Models

The commercial performance of "The Ferry Man" series further validates the viability of AIGC content as a financially sustainable production model. Through iQIYI's revenue-sharing model, the series recovered its full production costs within the first week and surpassed RMB8 million in cumulative box office within the first month, with figures continuing to grow. This rapid market feedback also enables producers to adjust subsequent creative decisions in a timely manner, reducing the time and cost of iteration.

The series also builds on iQIYI's continued exploration of long-form AIGC filmmaking, following "Mystic Tales - The Spider Lady's Vendetta" — China's first AIGC internet feature film released under an Internet Drama and Film Distribution License.

iQIYI Press

[email protected]

SOURCE iQIYI

Share this article

19.3% Weight Loss at Week 48: Phase Ⅲ Data of Olatorepatide, Hansoh's Dual‑Biased GLP‑1/GIP Agonist, Presented at EASD

MILAN, Oct. 2, 2026 /PRNewswire/ -- From September 28 to October 2, 2026, the Annual Meeting of the European Association for the Study of Diabetes (EASD) is being held in Milan, Italy. Hansoh Pharma's self-developed dual-biased glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide (GLP-1/GIP) receptor agonist, Olatorepatide (HS-20094), was presented as a Late-breaking Abstract (LBA) oral presentation, reporting the results from the Chinese Phase Ⅲ weight management study (LIGHTEN).

The findings show that Olatorepatide exhibits substantial weight‑loss efficacy and favorable gastrointestinal tolerability: Weight-loss Efficacy: Mean weight loss of 19.3% was achieved at Week 48 in the olatorepatide 15 mg group, with no weight-loss plateau observed; Waist-circumference Reduction: Mean waist-circumference reduction of 16.0 cm was observed in the olatorepatide 15 mg group; Low Incidence of Gastrointestinal Adverse Events: Nausea 7.8%; vomiting 4.9%. [1]

LIGHTEN is a multicenter, randomized, double-blind, placebo-controlled Phase III study conducted in Chinese adults with overweight or obesity, enrolling a total of 604 participants. Eligible participants had a BMI (Body Mass Index) ≥28kg/m², or a BMI of 24–28kg/m² accompanied by at least one weight-related comorbidity. Participants were randomized 1:1:1:1 to receive once-weekly subcutaneous injections of Olatorepatide 5mg, 10mg, 15mg, or placebo for 48 weeks. The co-primary endpoints were the percentage change in body weight from baseline at 48 weeks and the proportion of participants achieving ≥ 5% weight loss. Overall, 90.1% of participants completed the full 48-week treatment period.

Study results showed that under the efficacy estimand, mean body weight reductions at week 48 were −12.5%, −17.5% and −19.3% in the Olatorepatide 5 mg, 10 mg and 15 mg groups, respectively, versus −2.7% in the placebo group. Under the treatment-regimen estimand, mean body weight reductions were −11.8%, −17.0% and −18.7% across the three Olatorepatide dose groups, respectively, versus -2.5% in the placebo group. All between-group differences were statistically significant (P 0.0001).

In terms of weight loss goal achievement rates, under the efficacy estimand, the proportions for the Olatorepatide 5mg, 10mg, 15mg and placebo groups were as follows:

≥5% weight loss: 87.3%, 97.2%, 95.2% and 28.6%;

≥10% weight loss: 61.7%, 89.3%, 88.9% and 14.6%;

≥15% weight loss: 32.6%, 60.2%, 71.7% and 3.2%.

Notably, the weight loss curve showed a continued downward trend at Week 48, without reaching a plateau, suggesting that a longer treatment duration may yield further weight-loss benefits.

Under the efficacy estimand, mean reductions in waist circumference from baseline were 10.5cm, 14.4cm, and 16.0cm in the Olatorepatide 5mg, 10mg and 15mg groups, respectively, versus 3.6cm in the placebo group, with statistically significant differences (P 0.0001).

In addition, Olatorepatide brought improvements in metabolic parameters including blood pressure, lipid profiles, glycated hemoglobin (HbA1c), homeostatic model assessment for insulin resistance (HOMA‑IR), urine albumin-to-creatinine ratio (UACR) and uric acid, demonstrating comprehensive metabolic benefits.

The overall safety profile of Olatorepatide was similar to that of incretin-based therapies approved for weight management. Its incidence of gastrointestinal adverse events was notably lower than published data for currently available agents of the same class. The mean incidence of nausea, vomiting, diarrhea, and constipation in the Olatorepatide treatment groups was 7.8%, 4.9%, 16.9%, and 5.1%, respectively, versus 2.6%, 2.0%, 7.8%, and 1.3% in the placebo group. No participants discontinued treatment or withdrew early due to Olatorepatide treatment-related adverse events.

A dual-biased GLP-1/GIP receptor agonist, Olatorepatide offers a novel signaling pathway approach to overcoming the challenge of achieving both weight loss efficacy and tolerability. This Phase III weight-management study conducted in Chinese adults with overweight or obesity demonstrated significant weight loss efficacy along with favorable safety and tolerability, supporting its potential as a novel weight management therapy.

The EASD Annual Meeting is one of the most influential academic conferences in the global diabetes and metabolism field. The LBA sessions are dedicated to the latest research of high innovation and major scientific significance. The selection of the Phase III study of Olatorepatide for this LBA oral presentation reflects international peers' high recognition of its data quality and clinical value.

Olatorepatide Injection is a once-weekly subcutaneous dual-biased GLP‑1/GIP receptor agonist. It functions by modulating metabolic pathways governing appetite regulation, glucose metabolism, and energy balance. Olatorepatide is also currently in Phase III clinical development in China for the treatment of type 2 diabetes mellitus. In June 2025, Hansoh Pharmaceutical entered into a strategic collaboration with Regeneron, granting Regeneron exclusive overseas development and commercialization rights for the asset. In June 2026, the New Drug Application (NDA) for Olatorepatide Injection for long-term weight management in adults with overweight or obesity was accepted for review by the National Medical Products Administration (NMPA) of China.

Hansoh Pharma is a leading innovation-driven pharmaceutical company in China, with the mission of "Continuous innovation for better life". The Company focuses on major disease therapeutic areas such as oncology, metabolism, immunology, central nervous system ("CNS") and anti-infectives.

Share this article

The company is researching how AI agents can move beyond conversations to securely complete routine healthcare work.

SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- Healthcare can perform robotic surgery, sequence a genome and monitor a heart from a wrist. Yet moving an appointment, routing a refill, coordinating a referral or resolving an insurance question can still mean phone calls, handoffs and manual updates across systems.

It isn't because healthcare lacks software. Over the last two decades, much of healthcare has been digitized. But digitizing a workflow isn't the same as automating it.

Healthcare organizations operate across EHRs, scheduling systems, billing platforms, patient portals and other applications, each surrounded by privacy requirements, security controls and integration constraints. The result is often more software, but people still doing the work between the software.

MontoHealth is working on that gap

Instead of adding another system for healthcare teams to operate, MontoHealth is developing an action layer that can work across existing systems—understanding requests, coordinating workflows and taking permitted actions within defined boundaries.

The goal isn't another dashboard. It's less work between the dashboards.

Starting with patient communication

MontoHealth is starting with common patient interactions around appointments, prescription refills, referrals, billing and insurance questions, after-hours requests and multilingual communication.

But the conversation is only the entry point. When a patient asks to move an appointment or follow up on a referral, something needs to happen behind it. MontoHealth is researching how AI agents can carry that work forward across connected systems, with defined permissions and human involvement when judgment or approval is required.

The broader research extends into healthcare operations, data and research—exploring how specialized agents could work together without giving any single system unrestricted access or authority. MontoHealth remains under active development and is inviting a limited group of healthcare organizations into its Founding Physician Pilot Program to test early capabilities and help shape what the platform tackles next.

About MontoHealth

MontoHealth is a healthcare AI company developing intelligent agents that connect patient communication with the workflows and systems behind it.

Learn more and explore the Founding Physician Pilot Program at https://montohealth.ai/.

SOURCE montohealth.ai

Share this article

The all-new TUCSON embodies the "Boldest SUV" vision through its "Art of Steel" design, enhanced hybrid performance and intelligent efficiency, and advanced Pleos Connect infotainment system

A refined, spacious cabin enhances everyday comfort with intuitive controls, flexible storage and available relaxation features

Next-generation Hybrid System delivers intelligent efficiency, targeting up to 42 mpg while harmonizing fuel economy with dynamic driving performance

Pleos Connect drives everyday progress with an ever-evolving digital experience, enabled by Gleo AI, an expanding app marketplace, and intuitive UI/UX

TUCSON XRT PRO expands adventure capability with Smart Terrain Assist and advanced off-road technologies

Hyundai premieres the all-new TUCSON globally against the Manhattan skyline, showcasing the vehicle's progressive spirit and reinforcing its position as a global SUV icon.

NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Hyundai Motor Company today unveiled the all-new TUCSON, introducing its boldest SUV ever, which combines the "Art of Steel" design philosophy, hybrid performance enhanced by intelligent efficiency, and the advanced Pleos Connect next-generation infotainment system.

Hyundai Motor Unveils the All-New aTUCSON, Its Boldest SUV

The all-new TUCSON made its world premiere against the iconic backdrop of the Manhattan skyline in New York City, underscoring Hyundai Motor's confidence in its best-selling global SUV. The dynamic urban venue reflected the vehicle's progressive spirit, celebrating TUCSON's rich heritage as a global market leader while signaling a new era of versatile mobility.

Designed for ultimate versatility, the all-new TUCSON seamlessly transitions from sophisticated daily commutes to rugged weekend getaways. Guided by the "Art of Steel" design philosophy, it combines muscular exterior styling with a purposeful, tech-forward interior. Alongside the standard model, the debut of the rugged TUCSON XRT PRO further elevates its off-road capability. Integrated with Pleos Connect featuring Gleo AI, an advanced Next-generation Hybrid System, and Hyundai's first Smart Terrain Assist (STA), the all-new TUCSON lineup empowers customers with confidence and elevated convenience across diverse lifestyles and life stages.

"Millions of families around the world count on the Hyundai TUCSON, and this is the best one we have ever built," said José Muñoz, President and CEO, Hyundai Motor Company. "Its combination of bold design, generous cabin space, seamless infotainment, and available hybrid efficiency sets a new standard for what customers should expect in this segment. TUCSON opens the most ambitious product offensive in our history, including more than 100 new and refreshed vehicles globally by 2030 — 58 in North America alone."

[Explore The all-new TUCSON in Detail]

Watch the official all-new TUCSON launch film on Hyundai Worldwide's YouTube channel.

Discover key highlights about the all-new TUCSON [Link].

Share this article

Nuix Takes to Sibos 2026 to help Financial Institutions Turn Complex Data into Financial Crime Intelligence

MIAMI, Oct. 1, 2026 /PRNewswire/ -- Nuix, a global leader in investigative analytics and intelligence software, was at Sibos 2026 in Miami, where the company showcased how its Nuix Neo platform helps financial institutions uncover financial crime, build evidence, defensibly support prosecution and enable justice from within complex, unstructured data.

Up to 90% of enterprise data is unstructured, including emails, documents, chat, counterparty data, transaction records, case files, and voice, that conventional systems cannot read, meaning critical risk signals could be missed. While the financial services industry continues to invest heavily in artificial intelligence (AI), Nuix is drawing attention to a more fundamental challenge: ensuring the data underpinning those investments is complete, accessible, reliable and connected.

"AI is only as good as the data beneath it, and in complex financial crime investigations seeing and connecting all evidence is critical," said Chris Stephenson, Head of Industry Advocacy at Nuix.

Nuix Neo is an integrated, AI-enabled, unstructured data intelligence platform with a patented data processing engine that can extract information from complex data, processing over 1,000 file types with forensic precision, at a binary level. Deterministic natural language processing classifies and risk scores the data, while the platform's semantic search capabilities surface relevant documents based on meaning and context, across languages. Each step in the workflow seamlessly filters, minimizes, curates and prioritizes the data to reduce manual data review and optimize investigative outcomes. Every action is recorded at the point of processing rather than reconstructed afterwards, so an institution can show a regulator, a Financial Intelligence Unit (FIU) or a court how a conclusion was reached.

Nuix has integrated decision intelligence and graph analytics capabilities from its acquisition of Linkurious, into Nuix Neo to help financial crime teams visualize relationships across accounts, people, organizations and transactions. This allows analysts to explore how those entities are connected and identify sophisticated patterns across complex networks at scale.

"Financial crime teams are not short of alerts; they are short of certainty. When data is fragmented, unstructured, and complex, the work becomes piecing it together with the wider context to build a full picture. We do that part, so the team's hours go to the risk that matters and the decision is explainable and defensible end to end," said Stephenson.

"Once you can see the network, you can investigate the risk in context," said Stephenson. "With Nuix Neo analysts can follow a counterparty across accounts, jurisdictions and years of transaction history, and then show a regulator exactly how they got there."

Financial crime compliance teams can investigate the counterparty relationships, transaction patterns and connections that can be difficult to identify through traditional tabular analysis. They can analyze multi-hop relationships, overlay external enrichment sources and corporate registries to uncover sophisticated criminal schemes. Analysts can triage with confidence, and years of historical transaction data can be reprocessed to surface patterns earlier models missed.

Explainable, Defensible AI

Nuix Neo's responsible AI architecture incorporates deterministic scoring to drive explainable, auditable, and defensible outcomes. Organizations can also connect their own approved large language models with Nuix Neo's BYO-AI capability, maintaining data sovereignty and audit trails. As with any Gen AI capability, outputs remain probabilistic and must be verified against source material and are intended to support, not replace, the judgment of qualified investigators, analysts, reviewers, and legal professionals.

About Nuix

Nuix is a leading provider of investigative analytics and intelligence software, that empowers customers to be a force for good by finding truth in the digital world. We help customers collect, process and review large amounts of structured and unstructured data, making it searchable and actionable at scale and speed, with forensic accuracy.

For further information, please visit nuix.com

SOURCE Nuix

Share this article

Year-round United Express service to Denver and seasonal Delta Connection service to Salt Lake City begin at Canyonlands Regional Airport in October

MOAB, Utah, Oct. 1, 2026 /PRNewswire/ -- Canyonlands Regional Airport (CNY) will have air service to both Denver and Salt Lake City beginning in October, with United Express service launching Oct. 7 and Delta Connection service returning Oct. 1. Both flights are operated by SkyWest Airlines.

The new service gives travelers additional options for reaching Moab from two major hubs, with year-round service to Denver and seasonal service to Salt Lake City, as well as connections to destinations across the respective airline networks.

"New service from Denver and Salt Lake City makes Moab easier to reach from across the country and around the world," said Michael Soleta, director of the Moab Office of Tourism. "And once you're here, there's a lot more to Moab than you can fit into a day or two. Easier access gives travelers another reason to stay longer, explore more of the surrounding area and experience everything that makes Moab such a remarkable place."

The new United Express service between CNY and Denver International Airport (DEN) will operate year-round, with one or two daily roundtrip flights. The first flight is scheduled to depart Denver at 8 a.m. on Oct. 7 and arrive to Moab at 9:30 a.m. The return flight will depart CNY at 10:10 a.m. and arrive to Denver at 11:35 a.m.

Delta Connection service between CNY and Salt Lake City International Airport (SLC) will operate seasonally, with one daily roundtrip flight beginning Oct. 1. Service will operate through Thanksgiving before pausing and returning in March. The first flight is scheduled to depart SLC at 3:40 p.m. and arrives to Moab at 4:40 p.m., with return flight departing CNY at 5:36 p.m. and arriving to SLC at 6:40 p.m.

"We're excited to bring both United Express and Delta Connection service to the Moab community," said Cody Thomas, Managing Director of Market Development at SkyWest Airlines. "Having direct access to Denver and Salt Lake City, along with the ability to connect on United's and Delta's global networks, makes it easy and convenient for local travelers to get anywhere they want to go and allows new opportunities for those who want to experience this incredible region."

United flights are onboard the 50-passenger CRJ200 aircraft. Delta flights are onboard the 50-passenger CRJ550 aircraft, with Delta First, Delta Comfort and Delta Main seating.

Passengers can book flights at united.com or delta.com, or through the airline's mobile apps. Travelers will also earn MileagePlus miles on United Express flights and SkyMiles on Delta Connection flights.

For more information about visiting the Moab area, visit discovermoab.com.

About Moab Office of Tourism

Moab Office of Tourism is a department within Grand County Utah's local government unit, and is the official Destination Marketing Organization of the area. Grand County has a population of 9,700 residents in 3,700 square miles. Its largest municipality is Moab, Utah (population 5,200), a gateway town to two national parks (Arches and Canyonlands), two state parks (Dead Horse Point and Utahraptor), over 3 million acres of public lands, and the Colorado River. The area sees an estimated 2.5 million visitors annually. 

SOURCE Moab Office of Tourism

Share this article

In the news release, Dunn-Edwards Announces French Press Coffee as the 2027 Color of The Year, issued 01-Oct-2026 by Dunn-Edwards Corporation over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Dunn-Edwards Announces French Press Coffee as the 2027 Color of The Year

Featuring a whisper of warm purple, this deep, nuanced brown is the perfect elevated neutral, bringing lived-in luxury and restrained sophistication to any space.

LOS ANGELES, Oct. 1, 2026 /PRNewswire/ -- Today, Dunn-Edwards Corporation announced its 2027 Color of the Year, French Press Coffee (DEBN07), a deep, nuanced brown softened by a subtle plum undertone that embodies the rich character of roasted coffee and the enduring appeal of lived in luxury.

More than a trend color, French Press Coffee is an elevated neutral — one with enough dimension to anchor a space while maintaining a softness that feels livable and refined. It invites a moment of pause, evoking the ritual of a fresh cup of coffee and the focused, grounded energy that follows. Dark and atmospheric, yet restrained and sophisticated, this hue represents a clear shift in design toward depth, personality, and nuanced warmth for both contemporary and traditional styles.

Dunn-Edwards color experts identified a decisive shift away from the cool grays, stark whites, and flat beiges that have dominated recent years, in favor of warm, earthy hues.. French Press Coffee is the convergence of that movement — a warm, complex brown that feels both timeless and unexpected. More tailored than stark black and more refined than charcoal gray, it belongs to a new category of moody neutrals that upscale interiors have been gravitating toward.

"French Press Coffee is the kind of color that reveals itself gradually," said Lauren Hoferkamp, Color Marketing Manager at Dunn-Edwards. "As light shifts throughout the day, its subtle plum undertone emerges, adding complexity you don't always see in a neutral. It's grounding and restrained yet full of character. With its moody, rich hue, this color works beautifully across a wide range of spaces and applications."

French Press Coffee excels as a mood-setting backdrop, creating an enveloping atmosphere on walls that feels cozy and layered. In smaller, more intimate spaces such as a powder room, a study, or an entryway, color-drenching in French Press Coffee brings out the full complexity of its undertone and leans fully into lived-in luxury. In larger, light-filled rooms, it reads beautifully on fireplace surrounds, interior doors, and detailed trim, providing visual weight without overwhelming the space. On cabinetry, it introduces richness that feels elevated without demanding attention.

On exteriors, French Press Coffee brings a classic architectural quality to front doors, while functioning as an elevated alternative to black on shutters, garages, and trim paired with taupe, mushroom, or cream for contrast that never feels harsh.

French Press Coffee pairs well with earthy greens, clay tones, and soft creams, which complement the subtle plum undertone, while walnut, aged brass, honed marble, and linen textiles stand out beautifully against its dark, smoky presence.

For design professionals, French Press Coffee offers strong commercial adaptability across hospitality, multifamily, workplace, and retail. It brings personality and dimension to spaces without feeling flat or industrial, and can serve as a foundational background tone in projects where durability and longevity matter as much as aesthetic appeal.

As Dunn-Edwards enters its second century, French Press Coffee reflects the brand's commitment to timeless design, trusted expertise, and enduring color leadership. Classic without being stagnant, it anchors the full 2027 Color Trends collection, serving as a sophisticated neutral that allows the surrounding palette to breathe while carrying its own distinct story.

For more about the 2027 Color of the Year selection, including design and application inspiration, an immersive video, and more, visit Dunn-Edwards online.

About Dunn-Edwards Corporation Dunn-Edwards – Apply a Higher Standard. Dunn-Edwards is one of the nation's leading manufacturers and distributors of premium architectural, industrial, and high-performance paints, coatings, and paint supplies. It operates over 170 company stores in California, Arizona, Nevada, New Mexico and Texas, and over 100 domestic and over 350 international dealer locations in 14 countries. Dunn-Edwards is dedicated to preserving and protecting the environment and produces its coatings in a LEED® Gold-certified manufacturing plant. Based in Southern California, the 100-year-old company has approximately 1,800 employees. Dunn-Edwards is a wholly owned subsidiary of Osaka, Japan-based Nippon Paint Holdings Co., Ltd. (TYO 4612), one of the world's largest paint companies. For more information, visit www.dunnedwards.com.

Media Contact: Sonia Rodrigues -[email protected]/ 301.452.7852 Rodrigues PR

Correction: An earlier version of this release did not feature the seven added images.

Share this article

End-to-end service program combines fuel cell module performance guarantee with committed service response and resolution times, to enable transit operators to plan maintenance and fuel cell lifecycle costs.

CHICAGO, Oct. 1, 2026 /PRNewswire/ -- Ballard Power Systems is launching the first-of-its-kind fuel cell lifecycle programme – Ballard Fleet360 – at APTA TRANSform & EXPO 2026 in Chicago.

Available with new FCmove®-HD+ module sales in North America, the program connects intelligent fuel cell data, tailored technical support, parts assurance, technician training and refurbishment options. Fleet360's FCcare+ coverage package provides a fuel cell module performance guarantee for power output up to 250,000 miles of fuel cell operation.

"Transit operators want confidence in how their fuel cells perform today and as their fleets age," said Ralph Robinett, Chief Operating Officer of Ballard. "With Fleet360, we are backing our technology with a defined performance guarantee, supported by the information, parts and technical support maintenance teams need. This capability gives customers a clearer basis for planning fuel cell maintenance and lifecycle budgets, with performance commitments from Ballard."

Turning fuel cell data into maintenance decisions

At the center of Fleet360 is FCpulse, Ballard's digital platform for visibility into fuel cell health, performance and service-part trends. Its state of health dashboard helps maintenance teams proactively identify modules needing attention, prioritise investigations and prepare workshop resources. Its data visualizer access supports deeper technical investigation, while quarterly performance reports inform service and lifecycle planning.

Defined guarantees for module performance

The FCcare service package combines full parts coverage with commitments for response, spare part delivery and resolution, alongside FCpulse state of health dashboard access. The FCcare+ package adds a fuel cell module performance guarantee for power output power up to 250,000 miles of fuel cell operation. Guarantees and service commitments are defined by the package and agreement selected. Core+ refurbishment, Ballard Academy training and the full version of FCpulse are available alongside either package.

Service support built around fleet operations

The program is supported by Ballard's Remote Operations Centre in Vancouver, which coordinates triage, diagnostics and engineering escalation, together with expanded field service capability and US parts inventory in Bend, Oregon. The Ballard Academy builds customers' in-house maintenance capability and diagnostic skills, while Core+ connects stack condition assessment with refurbishment planning.

"Data creates value when it helps a maintenance team decide what to do next," Robinett added. "By connecting FCpulse insights with parts support, technical expertise and refurbishment planning, we can help operators prepare for maintenance and budget for the fuel cell module over its life. Our role is to give their teams the information and practical support to make those decisions with greater confidence."

Fleet360 builds on Ballard's experience across more than 186 million miles (300 million kilometers) of operational service and more than 3,000 fuel cell engines on the road. Today, Ballard has deployed nearly 330 fuel cell buses across North America, including over 225 buses in California and a fleet of more than 30 in Nevada.

Together, the market-leading FCmove® range of fuel cell engines and Ballard Fleet360 demonstrate Ballard's focus on the complete customer journey – from vehicle integration and deployment to reliable operation throughout the fleet lifecycle.

Ballard's presence at APTA EXPO 2026 also comes just weeks after the completion of its acquisition of GeoPura. The acquisition broadens Ballard's capabilities beyond fuel cell engines to include hydrogen production, logistics, refueling, and integrated Energy-as-a-Service solutions. These expanded capabilities strengthen Ballard's ability to support customers with the technology, services, and hydrogen solutions needed to deploy and operate zero-emission fleets at scale.

Meet Ballard at APTA EXPO 2026

Transit operators and bus manufacturers can meet Ballard's team at APTA EXPO 2026 to discuss Fleet360 coverage and service options. Visit us at Booth 462 from October 5-7.

About Ballard

Ballard Power Systems (NASDAQ: BLDP; TSX: BLDP) is a global leader in zero-emission hydrogen energy solutions and an integrated Energy-as-a-Service (EaaS) provider. Together, with its wholly owned subsidiary, GeoPura Ltd., Ballard delivers turnkey, vertically integrated hydrogen ecosystem solutions spanning hydrogen production, logistics, refuelling, zero-emission fuel cell engines, and stationary Hydrogen Power Units.

Ballard powers critical off-grid, stationary applications - including construction, events, film sets, healthcare, defense, temporary power infrastructure, and supplies fuel cell engines for heavy-duty mobility applications such as bus, rail, and marine. With an EaaS model, combined with cutting-edge technology across the hydrogen value chain, Ballard decarbonizes mission-critical operations worldwide. To learn more about Ballard, visit www.ballard.com.

Further Information

Sumit Kundu – Investor Relations, +1.604.360.3517 or [email protected]

SOURCE Ballard Power Systems Inc.

Share this article

Manulife Closes Long-Term Care Reinsurance Transaction with Munich Re

TORONTO, Oct. 1, 2026 /PRNewswire/ -- Manulife Financial Corporation ("Manulife" or the "Company") announced today that it has closed1 the previously announced transaction to reinsure biometric risk on a block of long-term care policies with $3.2 billion of reserves2 to Munich American Reassurance Company ("Munich Re Life US"), a subsidiary of Munich Re Group.

For more information on the transaction, please see the news release from our August 5th, 2026, announcement.

About Manulife

Manulife Financial Corporation is a leading international financial services provider, headquartered in Toronto, Canada. Anchored in our ambition to be the number one choice for customers, we operate as Manulife across Canada and Asia, and primarily as John Hancock in the United States, providing financial advice, insurance and health solutions for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment solutions, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2025, we had more than 37,000 employees, over 106,000 agents, and thousands of distribution partners, serving over 37 million customers with operations across 25 markets globally. We trade as 'MFC' on the Toronto, New York, and Philippine stock exchanges, and under '945' on the Hong Kong stock exchange.

About Munich Re Life US

Munich Re Life US, a subsidiary of Munich Re Group, is a leading US reinsurer with a significant market presence and extensive technical depth in all areas of life and disability reinsurance. Beyond vast reinsurance capacity and unrivaled risk expertise, the company is recognized as an innovator in digital transformation and aims to guide carriers through the changing industry landscape with dynamic solutions insightfully designed to grow and support their business. Munich Re Life US also offers tailored financial reinsurance solutions to help life and disability insurance carriers manage organic growth and capital efficiency as well as M&A support to help achieve transaction success.

Media Inquiries

Fiona McLean

(437) 441-7491

[email protected]

Investor Relations

Derek Theobalds

(416) 254-1774

[email protected]

SOURCE Manulife Financial Corporation

Share this article

Angel Aligner Upgrades Torque Ridges to "Pressure Points" in Europe

New Feature Improves Torque Control by Leveraging Pressure Points and Trimline Options

SAN CLEMENTE, Calif., Oct. 2, 2026 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") http://www.angelaligner.com, a global trailblazer in orthodontic clear aligner technology, today announced the launch of Pressure Points in the European market, an upgraded feature that replaces the company's current Torque Ridges. The upgrade reflects Angel's continued commitment to innovation focused on solving orthodontists' clinical challenges.

Pressure Points is the result of Angel's ongoing research initiatives, which concentrate on improving clinical predictability and effectiveness. The feature will initially launch for torque corrections in a single configuration and is expected to expand to rotation and intrusion.

From Torque Ridges to Pressure Points

Angel Aligner's high trimline options provide a clinical tool for more effective torque expression by covering the entire tooth surface and up to 2mm of the gingiva.

Hand-made dimples have long been used to help aligners apply targeted force to teeth for correction of torque and rotation by clinicians. Building on observations from its research, Angel engineered Pressure Points to make the force application more predictable than current methods.

The new Pressure Points has been engineered to deliver:

- Predictable force application: The simplified dimple shape allows for the force to be applied at or close to the center of the pressure point.

- Greater tooth contact: A 25% increase in tooth surface contact in the single pressure point configuration allows better control of tooth movement when a scalloped trimline is used.

- Accuracy and scalability: Pressure Points opens the way for more digital accuracy and scalability than hand-made pressure points.

Continuing a Legacy of Clinical Innovation

Pressure Points is now available to orthodontists in Europe with global distribution planned.

Engineering research and clinical feedback will guide the introduction of further innovations and additional configurations.

In addition, Angel plans to give orthodontists who use Pressure Points more control of patients' treatment plans.

"Our commitment to research and to delivering innovative solutions for our customers and their patients began many years ago, including with the launch of the angelButton™. Today, we continue that journey with the launch of our upgraded solution, Pressure Points," said Xavier Cherbavaz, General Manager and Vice President, Europe, Africa, and the Middle East, Angelalign Technology Inc.

To learn more, visit angelaligner.com/eu and www.angelaligner.com.

About Angelalign Technology Inc.

Founded in 2003 and publicly listed since 2021, Angelalign Technology Inc. provides clear aligner solutions to clinically focused professionals and patients in over 60 countries. Having surpassed two million cumulative cases and with about a US$2 billion market capitalization, the company focuses on clinical innovation and professional support to help experts achieve extraordinary outcomes. Learn more at angelaligner.com.

Media Contact:

Sue Kolb

Angelalign Technology Inc.

[email protected]

Share this article